pubmed-article:19223753 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19223753 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
pubmed-article:19223753 | lifeskim:mentions | umls-concept:C0279628 | lld:lifeskim |
pubmed-article:19223753 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
pubmed-article:19223753 | lifeskim:mentions | umls-concept:C0851346 | lld:lifeskim |
pubmed-article:19223753 | lifeskim:mentions | umls-concept:C0444889 | lld:lifeskim |
pubmed-article:19223753 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:19223753 | lifeskim:mentions | umls-concept:C1533148 | lld:lifeskim |
pubmed-article:19223753 | lifeskim:mentions | umls-concept:C0332173 | lld:lifeskim |
pubmed-article:19223753 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:19223753 | lifeskim:mentions | umls-concept:C0093999 | lld:lifeskim |
pubmed-article:19223753 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:19223753 | pubmed:dateCreated | 2009-2-19 | lld:pubmed |
pubmed-article:19223753 | pubmed:abstractText | We report an elderly patient with esophageal adenocarcinoma in whom a complete response (CR) was obtained by chemoradiotherapy using daily low-dose nedaplatin (CDGP) and continuous infusion of 5-FU. A 86-year-old man who had non-tuberculous mycobacterial infection was admitted for dysphagia, and diagnosed with Stage II A (T2N0M0) esophageal adenocarcinoma of the lower esophagus according to the TNM classification (sixth edition) of the International Union against Cancer (UICC). Chemoradiotherapy using daily low-dose CDGP and continuous infusion of 5- FU was performed, and thereafter one cycle of chemotherapy using CDGP and 5-FU was added. As the side effects of treatment, grade 3 leucopenia was observed while he was receiving chemoradiotherapy. A year later, he presented with grade 2 pericardial and pleural effusion and recovered with conservative treatment. CR was obtained and has been continued for two years. Definitive chemoradiotherapy using daily low-dose CDGP and continuous infusion of 5-FU is an effective choice for elderly and high-risk patients with esophageal adenocarcinoma. | lld:pubmed |
pubmed-article:19223753 | pubmed:language | jpn | lld:pubmed |
pubmed-article:19223753 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19223753 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19223753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19223753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19223753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19223753 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19223753 | pubmed:month | Feb | lld:pubmed |
pubmed-article:19223753 | pubmed:issn | 0385-0684 | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:IkumaMutsuhir... | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:FurutaTakahis... | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:YoshidaKen-ic... | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:SugimotoKenK | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:KodairaChiseC | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:YamadaTakanor... | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:IwaizumiMoriy... | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:FutamiHajimeH | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:MuramatsuAkik... | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:OsawaSatoshiS | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:HamayaYasushi... | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:TakagakiKosuk... | lld:pubmed |
pubmed-article:19223753 | pubmed:author | pubmed-author:NishinoMasafu... | lld:pubmed |
pubmed-article:19223753 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19223753 | pubmed:volume | 36 | lld:pubmed |
pubmed-article:19223753 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19223753 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19223753 | pubmed:pagination | 309-12 | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:meshHeading | pubmed-meshheading:19223753... | lld:pubmed |
pubmed-article:19223753 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19223753 | pubmed:articleTitle | [A case of elderly esophageal adenocarcinoma successfully treated with daily low-dose nedaplatin (CDGP) and continuous infusion of 5-FU combined with radiation]. | lld:pubmed |
pubmed-article:19223753 | pubmed:affiliation | First Dept. of Medicine, Hamamatsu University School of Medicine. | lld:pubmed |
pubmed-article:19223753 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19223753 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:19223753 | pubmed:publicationType | Case Reports | lld:pubmed |